Wanda Filer, MD, MBA, FAAFP, discusses the prevalence of RSV.
Considerations for the Management of Respiratory Syncytial Virus (RSV)
Wanda Filer, MD, MBA, FAAFP, provides an overview of the potential outcomes for patients of all ages with RSV.
Dr Filer highlights the considerations for the rollout of new RSV vaccines.
Financial burden associated with RSV treatment is explored by a medical expert.
In her closing thoughts, Dr Filer provides insights into the unmet needs in the treatment of RSV.
Advertisement
Advertisement
Trending on AJMC
1
Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps
2
Patients With Long-Term Conditions Prefer Remote Visits for Routine Care
3
Employer Premiums and Deductibles Consume Significant Portion of Income in 19 States
4
Scaling Innovation in Advanced Multiple Myeloma Care Delivery: A Q&A With Ameet Patel, MD
5